Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
0.964
-0.016 (-1.66%)
At close: Dec 20, 2024, 4:00 PM
0.990
+0.026 (2.74%)
After-hours: Dec 20, 2024, 7:36 PM EST
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $121.23 million as of December 20, 2024. Its market cap has increased by 31.49% in one year.
Market Cap
121.23M
Enterprise Value
46.47M
1-Year Change
31.49%
Ranking
Category
Stock Price
$0.96
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $121.23M, an increase of 95.54%. That is a compound annual growth rate of 5.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 20, 2024 | 121.30M | 9.97% |
Dec 29, 2023 | 110.30M | 64.87% |
Dec 30, 2022 | 66.90M | -66.98% |
Dec 31, 2021 | 202.60M | 197.94% |
Dec 31, 2020 | 68.00M | 375.52% |
Dec 31, 2019 | 14.30M | 146.55% |
Dec 31, 2018 | 5.80M | -17.14% |
Dec 29, 2017 | 7.00M | 32.08% |
Dec 30, 2016 | 5.30M | -45.36% |
Dec 31, 2015 | 9.70M | -72.36% |
Dec 31, 2014 | 35.10M | -16.03% |
Dec 31, 2013 | 41.80M | -17.06% |
Dec 31, 2012 | 50.40M | -18.71% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Monopar Therapeutics | 125.56M |
Galectin Therapeutics | 125.52M |
InflaRx | 125.42M |
Enanta Pharmaceuticals | 124.20M |
Black Diamond Therapeutics | 123.92M |
Elutia | 122.00M |
American Well | 120.11M |
Applied Therapeutics | 118.68M |